2025
SJR Q2
JCR Q2 · 2,2
47 matched articles
SCIE
Journal detail
ASAIO Journal
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
105829161538943X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,732
- Quartile Q2
- H-Index 85
- Cites/doc 1,98
- Docs (3y) 788
- Cites (3y) 1.745
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,2
- 5Y JIF 2,5
- JCI 0,66
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Bioengineering Q2
- Biomaterials Q2
- Biomedical Engineering Q2
- Biophysics Q2
- Medicine (miscellaneous) Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Chemical Engineering
- Engineering
- Materials Science
- Medicine
WoS categories
- Engineering, Biomedical | Transplantation
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,732 | 2,2 | 2,5 | 0,66 | Q2 | 85 |
| 2024 | Q1 | Q2 | 0,895 | 2,3 | 2,6 | 0,81 | Q2 | 82 |
| 2023 | Q1 | Q2 | 0,993 | 3,1 | 2,8 | 0,98 | Q1 | 82 |
| 2022 | Q1 | Q2 | 0,995 | 4,2 | 3,6 | 1,03 | Q1 | 82 |
| 2021 | Q1 | Q2 | 0,859 | 3,8 | 3,3 | 0,94 | Q2 | 82 |
| 2020 | Q1 | Q3 | 0,961 | 2,9 | 3 | 0,85 | Q2 | 82 |
| 2019 | Q1 | Q2 | 1,086 | 2,7 | 2,2 | 0,77 | Q2 | 82 |
| 2018 | — | Q2 | — | 2,5 | 2,4 | 0,8 | Q2 | — |
| 2017 | Q2 | Q3 | 0,771 | 1,8 | 2 | 0,7 | Q2 | 82 |
| 2016 | Q1 | Q2 | 0,963 | 2,2 | 2,1 | — | — | 82 |
| 2015 | Q1 | Q2 | 0,993 | 2,3 | 1,9 | — | — | 82 |
| 2014 | Q2 | Q3 | 0,755 | 1,5 | 1,4 | — | — | 82 |
| 2013 | Q2 | Q3 | 0,65 | 1,4 | 1,4 | — | — | 82 |
| 2012 | Q2 | Q3 | 0,644 | 1,5 | 1,2 | — | — | 82 |
| 2011 | Q2 | Q3 | 0,679 | 1,4 | 1,4 | — | — | 82 |
| 2010 | Q2 | Q3 | 0,638 | 1,2 | 1,3 | — | — | 82 |
| 2009 | — | Q3 | — | 1,4 | 1,4 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 1,5 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,3 | — | — | — |
| 2006 | — | Q2 | — | 1,5 | — | — | — | — |
| 2005 | — | Q3 | — | 1,1 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 1,1 | — | — | — | — |
| 2002 | — | Q2 | — | 1 | — | — | — | — |
| 2001 | — | Q2 | — | 1,2 | — | — | — | — |
| 2000 | — | Q2 | — | 1,2 | — | — | — | — |
| 1999 | — | Q2 | — | 1 | — | — | — | — |
| 1998 | — | Q2 | — | 0,9 | — | — | — | — |
| 1997 | — | Q2 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 89/130 |
| 2025 | TRANSPLANTATION | SCIE | Q2 | Q2 | 14/30 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 81/124 |
| 2024 | TRANSPLANTATION | SCIE | Q2 | Q2 | 13/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 59/123 |
| 2023 | TRANSPLANTATION | SCIE | Q2 | Q1 | 11/31 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 40/96 |
| 2022 | TRANSPLANTATION | SCIE | Q2 | Q1 | 8/26 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 51/98 |
| 2021 | TRANSPLANTATION | SCIE | Q2 | Q2 | 11/25 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 51/89 |
| 2020 | TRANSPLANTATION | SCIE | Q3 | Q2 | 14/25 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 37/87 |
| 2019 | TRANSPLANTATION | SCIE | Q2 | Q2 | 12/24 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 31/80 |
| 2018 | TRANSPLANTATION | SCIE | Q3 | Q2 | 14/25 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 48/78 |
| 2017 | TRANSPLANTATION | SCIE | Q3 | Q3 | 16/25 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 35/77 |
| 2016 | TRANSPLANTATION | SCIE | Q3 | — | 15/25 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 26/76 |
| 2015 | TRANSPLANTATION | SCIE | Q3 | — | 14/25 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 43/76 |
| 2014 | TRANSPLANTATION | SCIE | Q3 | — | 17/25 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 46/76 |
| 2013 | TRANSPLANTATION | SCIE | Q4 | — | 22/26 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 45/79 |
| 2012 | TRANSPLANTATION | SCIE | Q4 | — | 20/26 |
| 2011 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 46/72 |
| 2011 | TRANSPLANTATION | SCIE | Q4 | — | 20/24 |
| 2010 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 44/70 |
| 2010 | TRANSPLANTATION | SCIE | Q4 | — | 20/25 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 41/59 |
| 2009 | TRANSPLANTATION | SCIE | Q4 | — | 19/24 |
| 2008 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 31/52 |
| 2008 | TRANSPLANTATION | SCIE | Q4 | — | 17/21 |
| 2007 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 26/44 |
| 2007 | TRANSPLANTATION | SCIE | Q4 | — | 17/21 |
| 2006 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 21/42 |
| 2006 | TRANSPLANTATION | SCIE | Q4 | — | 16/19 |
| 2005 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 26/41 |
| 2005 | TRANSPLANTATION | SCIE | Q4 | — | 17/20 |
| 2004 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 30/42 |
| 2004 | TRANSPLANTATION | SCIE | Q4 | — | 16/19 |
| 2003 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 22/42 |
| 2003 | TRANSPLANTATION | SCIE | Q4 | — | 14/18 |
| 2002 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 19/40 |
| 2002 | TRANSPLANTATION | SCIE | Q4 | — | 15/17 |
| 2001 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 14/39 |
| 2001 | TRANSPLANTATION | SCIE | Q3 | — | 11/16 |
| 2000 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 17/41 |
| 2000 | TRANSPLANTATION | SCIE | Q4 | — | 13/16 |
| 1999 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 19/43 |
| 1999 | TRANSPLANTATION | SCIE | Q3 | — | 12/17 |
| 1998 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 22/45 |
| 1997 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | — | 15/41 |